T-Cell Receptor Therapy in the Treatment of Ovarian Cancer: A Mini Review

Ovarian cancer, in particularly high-grade serous ovarian cancer (HGSOC) and ovarian carcinosarcoma (OCS), are highly aggressive and deadly female cancers with limited treatment options. These tumors are generally unresponsive to immune check-point inhibitor (ICI) therapy and are referred to as immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jessica W. Y., Dand, Sudiksha, Doig, Lachlan, Papenfuss, Anthony T., Scott, Clare L., Ho, Gwo, Ooi, Joshua D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076633/
https://www.ncbi.nlm.nih.gov/pubmed/33927729
http://dx.doi.org/10.3389/fimmu.2021.672502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076633/
https://www.ncbi.nlm.nih.gov/pubmed/33927729
http://dx.doi.org/10.3389/fimmu.2021.672502

Ejemplares similares